GlaxoSmithKline plc (GSK) Rating Reiterated by Societe Generale

GlaxoSmithKline plc (GSK) Rating Reiterated by Societe Generale


's stock had its "sell" rating reaffirmed by Societe Generale in a research report issued to clients and investors on Thursday, ARN reports. They currently have a GBX 1,250 price target on the stock.



from Biotech News